Trials / Completed
CompletedNCT00888745
A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I multicenter study that will be conducted in the United States and Europe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | Intravenous and subcutaneous ascending dose |
| DRUG | PRO283698 | Intravenous and subcutaneous ascending dose |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-06-01
- First posted
- 2009-04-28
- Last updated
- 2010-12-01
Locations
12 sites across 2 countries: United States, Hungary
Source: ClinicalTrials.gov record NCT00888745. Inclusion in this directory is not an endorsement.